Newsfeeds Archive - Page 33 of 56

2 minute read

COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials

February 28, 3:55 PM

Mental healthcare biotech COMPASS Pathways (NASDAQ: CMPS) reported its financial results for the fourth quarter and year-end 2022 and provided an update on recent pipeline and business progress. Numbers show:

CMPS

2 minute read

Shark Tank’s Kevin Harrington Will Provide Strategic Guidance To Major Psychedelics Company

By Lara Goldstein

February 28, 3:29 PM

Psychedelics biopharma company FSD Pharma Inc. (NASDAQ: HUGE)’s advisory board has a new member: the iconic entrepreneur and inventor of the infomercial Kevin Harrington.

HUGE

5 minute read

Psyched: Hawaii And Minnesota’s Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry’s Future And More

By Lara Goldstein

February 27, 8:28 PM

Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and psilocybin as an alternative to treat mental health conditions.

AGNPF

3 minute read

Red Light Holland’s Q3 2023 Financials: Expanded Farms Division, Home Grow Kits & Revenue Increase

By Lara Goldstein

February 27, 2:10 PM

Ontario-based mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its interim financial results for the third fiscal quarter of 2023 -three and nine months- ended December 31, 2022.

TRUFF

1 minute read

Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind

By Lara Goldstein

February 22, 2:43 PM

Specialty R&D psychedelics company PharmaDrug Inc. (OTCQB: LMLLF) has inked a research collaboration agreement with PharmaTher Holdings Ltd. (OTCMKTS: PHRRF) to evaluate the delivery of DMT through PharmaTher's microneedle patch technology.

LMLLF

2 minute read

Awakn’s First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics

By Lara Goldstein

February 22, 2:28 PM

Awakn Life Sciences Corp. (OTCQB: AWKNF) has signed a licensing partnership agreement in Europe with a Portugal-based healthcare consortium currently operating in stealth mode.

AWKNF

6 minute read

Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More

By Lara Goldstein

February 21, 6:19 PM

Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and added to the list of measures calling for some sort of psychedelics legalization, while some of the already filed ones continue progressing and others get a thumbs down.

AGNPF

1 minute read

Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants

By Lara Goldstein

February 17, 2:44 PM

Numinus Wellness (OTCQX: NUMIF) expanded its clinical research capabilities into Phoenix, where the psychedelic-assisted therapy provider currently operates mental health clinics.

NUMIF

2 minute read

Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation

By Lara Goldstein

February 16, 2:52 PM

Delix Nabs 2 New Partners Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience. The goal is to expedite Delix's drug development pipeline.

PSYCF

2 minute read

Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose

By Lara Goldstein

February 16, 2:38 PM

Algernon Pharmaceuticals (OTCQB: AGNPF)’s subsidiary Algernon NeuroScience has completed the first cohort in its Phase 1 clinical study of

AGNPF